Chemoinformaics analysis of 3-O-trans-caffeoyltormentic acid
| Molecular Weight | 770.69 | nRot | 9 |
| Heavy Atom Molecular Weight | 728.354 | nRig | 36 |
| Exact Molecular Weight | 770.227 | nRing | 6 |
| Solubility: LogS | -3.668 | nHRing | 4 |
| Solubility: LogP | -1.06 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 96 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 54 | No. of Aromatic Carbocycles | 2 |
| nHetero | 20 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 34 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 20 | No. of Arom Bond | 17 |
| nHA | 20 | APOL | 100.825 |
| nHD | 11 | BPOL | 56.8907 |
| QED | 0.107 |
| Synth | 5.378 |
| Natural Product Likeliness | 1.827 |
| NR-PPAR-gamma | 0.959 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.994 |
| HIA | 0.979 |
| CACO-2 | -6.332 |
| MDCK | 0.000122741 |
| BBB | 0.184 |
| PPB | 0.755559 |
| VDSS | 0.567 |
| FU | 0.275996 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.042 |
| CYP2c19-inh | 0.007 |
| CYP2c19-sub | 0.059 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.247 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.151 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.002 |
| CL | 0.864 |
| T12 | 0.299 |
| hERG | 0.01 |
| Ames | 0.658 |
| ROA | 0.032 |
| SkinSen | 0.007 |
| Carcinogencity | 0.08 |
| EI | 0.004 |
| Respiratory | 0.01 |
| NR-Aromatase | 0.913 |
| Antiviral | Yes |
| Prediction | 0.769284 |